Dr. Reddy's Laboratories Limited (RDY) Q4 2025 Earnings Call Transcript
https://seekingalpha.com/article/4784662-dr-reddys-laboratories-limited-rdy-q4-2025-earnings-call-transcript?source=feed_tag_india
May 09, 2025 -
0
Dr. Reddy's (RDY), Kainomyx Sign Potential Deal for Malaria Drug
https://www.zacks.com/stock/news/2325189/dr-reddy-s-rdy-kainomyx-sign-potential-deal-for-malaria-drug?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2325189
Aug 21, 2024 - Dr. Reddy's (RDY) is gearing up to potentially collaborate with Kainomyx to jointly develop an affordable anti-malarial drug.
0
Dr. Reddy's (RDY) Q1 Earnings Miss Estimates, Revenues Beat
https://www.zacks.com/stock/news/2311082/dr-reddy-s-rdy-q1-earnings-miss-estimates-revenues-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2311082
Jul 29, 2024 - Dr. Reddy's (RDY) reports mixed first-quarter fiscal 2025 results, wherein earnings lag estimates, but revenues beat the same, driven by growth in global generics sales in North America and India.
0
Dr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
https://www.zacks.com/stock/news/2277488/dr-reddy-s-rdy-alvotech-unite-for-prolia-xgeva-biosimilar?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2277488
May 22, 2024 - Dr. Reddy's (RDY) announces entering into a license and supply agreement with Alvotech to develop and commercialize the latter's biosimilar candidate, AVT03, to Prolia and Xgeva.
0
Dr. Reddy's Laboratories Limited (RDY) Q4 2024 Earnings Call Transcript
https://seekingalpha.com/article/4690298-dr-reddys-laboratories-limited-rdy-q4-2024-earnings-call-transcript?source=feed_tag_india
May 07, 2024 - Dr. Reddy's Laboratories Limited (NYSE:NYSE:RDY) Q4 2024 Earnings Conference Call May 7, 2024 10:00 AM ETCompany ParticipantsRicha Periwal - Head of...
0
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
https://www.zacks.com/commentary/2257822/3-generic-drug-stocks-to-watch-amid-challenging-market-prospects?cid=CS-ZC-FT-industry_outlook-2257822
Apr 18, 2024 - The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, TEVA and VTRS.
0
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2251159/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2251159
Apr 05, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2233209/why-doctor-reddy-s-rdy-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2233209
Feb 28, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Why Doctor Reddy's (RDY) is a Top Growth Stock for the Long-Term
https://www.zacks.com/stock/news/2230194/why-doctor-reddy-s-rdy-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2230194
Feb 22, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2221076/why-doctor-reddy-s-rdy-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2221076
Feb 05, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Pages: 12
Page 1